ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2016
Identifying Patients With COPD at High Risk of Readmission.
Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05906264 (Evaluation of Compliance and Effectiveness of Pulmonary Rehabilitation Program in COPD Patient), which is not on this map. Cited by 30 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of Compliance and Effectiveness of Pulmonary Rehabilitation Program in COPD Patient
Who cites it
30 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) - A Systematic Review.International journal of chronic obstructive pulmonary disease · 2023Pooled it
- Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2020Pooled it
- Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis.Respiratory research · 2020Pooled it
- Practical strategies for achieving system change in the US: lessons and insights from the CONQUEST quality improvement programme.Primary health care research & development · 2025Review
- Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies.Medicina (Kaunas, Lithuania) · 2025Review
- Disparities in Discharge Support Provided to Patients Leaving "Before Medically Advised" from Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation.Annals of the American Thoracic Society · 2025Article
- Exploring risk factors for all-cause hospital readmissions following chronic obstructive pulmonary disease exacerbation patients discharged on steroid tapers.Journal of thoracic disease · 2024Article
- Review
- Factors affecting 12-month unplanned readmissions for chronic obstructive pulmonary disease patients: the effect of mental disorders in an Australian cohort.Journal of public health (Oxford, England) · 2024Article
- Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium Therapy.International journal of chronic obstructive pulmonary disease · 2024Article
- Community Paramedicine Intervention Reduces Hospital Readmission and Emergency Department Utilization for Patients with Cardiopulmonary Conditions.The western journal of emergency medicine · 2023Observational
- 30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary Care Hospital.International journal of chronic obstructive pulmonary disease · 2023Article
- Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.American journal of respiratory and critical care medicine · 2022Article
- 30-day Readmission After an Acute Exacerbation of Chronic Obstructive Pulmonary Disease is Associated with Cardiovascular Comorbidity.Turkish thoracic journal · 2021Article
- Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.Pulmonary therapy · 2021Article
- Age-Dependent Associations Between 25-Hydroxy Vitamin D Levels and COPD Symptoms: Analysis of SPIROMICS.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2021Article
- Telemedicine Services in Chronic Obstructive Pulmonary Disease: A Systematic Review of Patients' Adherence.Tanaffos · 2021Review
- Weak Handgrip at Index Admission for Acute Exacerbation of COPD Predicts All-Cause 30-Day Readmission.Frontiers in medicine · 2021Article
- Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk.International journal of chronic obstructive pulmonary disease · 2020Observational
- Reducing the Number of Hospitalization Days for COPD: Setting up a Transmural-Care Pathway.International journal of chronic obstructive pulmonary disease · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.